Freenome, Inc.
corporate_fare Company Profile
Freenome, Inc. (NASDAQ:PCSC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 24 items for PCSC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-27, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 17 rated 8 or above. Recent SEC coverage for PCSC spans 8-K, SCHEDULE 13D/A, 10-Q, 424B3.
Recent high-impact activity:
- FDA Clears Freenome's SimpleScreen CRC Blood Test, Triggering $100M Abbott Milestone
- Freenome closes SPAC merger, raises $310M, and begins trading as FRNM
- RA Capital Discloses 14.3% Stake in Freenome Post-Merger, Including $52.6M PIPE Investment
- PCSC Shareholders Clear Final Hurdle, Approving SPAC Merger with Freenome
- SPAC Swings to Loss, Cash Dwindles to $437K as Merger Deadline Extended
Dilution Risk
Low riskFiling-implied dilution signals for PCSC, detected from its recent SEC filings · based on capital-structure filings through 2026-07-09.
SPAC Merger Finalized · Critical PIPE Financing Secured
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →